Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells

We examined the effect of intact human mast cells (HMC-1 5C6) and their selected mediators on interleukin-6 (IL-6) production and bone morphogenetic protein-2 (BMP-2) expression in human coronary artery endothelial cells (HCAEC) in the presence and absence of lipopolysaccharide (LPS). Scanning elect...

Full description

Saved in:
Bibliographic Details
Main Authors: Damandeep S. Walia, Mukut Sharma, Vineesh V. Raveendran, Jianping Zhou, Ram Sharma, Daniel J. Stechschulte, Kottarappat N. Dileepan
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/274347
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549887569297408
author Damandeep S. Walia
Mukut Sharma
Vineesh V. Raveendran
Jianping Zhou
Ram Sharma
Daniel J. Stechschulte
Kottarappat N. Dileepan
author_facet Damandeep S. Walia
Mukut Sharma
Vineesh V. Raveendran
Jianping Zhou
Ram Sharma
Daniel J. Stechschulte
Kottarappat N. Dileepan
author_sort Damandeep S. Walia
collection DOAJ
description We examined the effect of intact human mast cells (HMC-1 5C6) and their selected mediators on interleukin-6 (IL-6) production and bone morphogenetic protein-2 (BMP-2) expression in human coronary artery endothelial cells (HCAEC) in the presence and absence of lipopolysaccharide (LPS). Scanning electron microscopy showed that HMC-1 5C6 cells adhere to HCAEC in cocultures. Addition of HMC-1 5C6 cells markedly enhanced the IL-6 production by quiescent and LPS-activated HCAEC even at the maximal concentration of LPS. Furthermore, mast cell-derived histamine and proteases accounted for the direct and synergistic effect of mast cells on IL-6 production that was completely blocked by the combination of histamine receptor-1 antagonist and protease inhibitors. Another novel finding is that histamine was able to induce BMP-2 expression in HCAEC. Collectively, our results suggest that endotoxin and mast cell products synergistically amplify vascular inflammation and that histamine participates in the early events of vascular calcification.
format Article
id doaj-art-cb0ceae9e5994d84a5245abfb18ce4c6
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-cb0ceae9e5994d84a5245abfb18ce4c62025-02-03T06:08:23ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/274347274347Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial CellsDamandeep S. Walia0Mukut Sharma1Vineesh V. Raveendran2Jianping Zhou3Ram Sharma4Daniel J. Stechschulte5Kottarappat N. Dileepan6Division of Allergy, Clinical Immunology, and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAKansas City, Veterans Affairs Medical Center, Kansas City, MO 64128, USADivision of Allergy, Clinical Immunology, and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAKansas City, Veterans Affairs Medical Center, Kansas City, MO 64128, USAKansas City, Veterans Affairs Medical Center, Kansas City, MO 64128, USADivision of Allergy, Clinical Immunology, and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USADivision of Allergy, Clinical Immunology, and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAWe examined the effect of intact human mast cells (HMC-1 5C6) and their selected mediators on interleukin-6 (IL-6) production and bone morphogenetic protein-2 (BMP-2) expression in human coronary artery endothelial cells (HCAEC) in the presence and absence of lipopolysaccharide (LPS). Scanning electron microscopy showed that HMC-1 5C6 cells adhere to HCAEC in cocultures. Addition of HMC-1 5C6 cells markedly enhanced the IL-6 production by quiescent and LPS-activated HCAEC even at the maximal concentration of LPS. Furthermore, mast cell-derived histamine and proteases accounted for the direct and synergistic effect of mast cells on IL-6 production that was completely blocked by the combination of histamine receptor-1 antagonist and protease inhibitors. Another novel finding is that histamine was able to induce BMP-2 expression in HCAEC. Collectively, our results suggest that endotoxin and mast cell products synergistically amplify vascular inflammation and that histamine participates in the early events of vascular calcification.http://dx.doi.org/10.1155/2012/274347
spellingShingle Damandeep S. Walia
Mukut Sharma
Vineesh V. Raveendran
Jianping Zhou
Ram Sharma
Daniel J. Stechschulte
Kottarappat N. Dileepan
Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
Mediators of Inflammation
title Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
title_full Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
title_fullStr Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
title_full_unstemmed Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
title_short Human Mast Cells (HMC-1 5C6) Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
title_sort human mast cells hmc 1 5c6 enhance interleukin 6 production by quiescent and lipopolysaccharide stimulated human coronary artery endothelial cells
url http://dx.doi.org/10.1155/2012/274347
work_keys_str_mv AT damandeepswalia humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells
AT mukutsharma humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells
AT vineeshvraveendran humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells
AT jianpingzhou humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells
AT ramsharma humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells
AT danieljstechschulte humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells
AT kottarappatndileepan humanmastcellshmc15c6enhanceinterleukin6productionbyquiescentandlipopolysaccharidestimulatedhumancoronaryarteryendothelialcells